Evidence map›Paper›PMID 39528875›Full record

ArticleMolecular biomedicine2024

Proteogenomics identifies c-Met inhibition as a therapeutic strategy for BAP1-deficient clear cell renal cell carcinoma.

Bowen Du, Yulin Zhou, Wenzhi Li, Haowei He, Ming Chen, Ninghan Feng

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular biomedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bowen Du *Department of Urology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. dubwac@gmail.com.ORCID 0000-0002-9571-9290
Yulin Zhou *Department of Urology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Wenzhi Li *Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Haowei HeDepartment of Urology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. hohowell@163.com.
Ming ChenDepartment of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, China. mingchen0712@seu.edu.cn.
Ninghan FengDepartment of Urology, Jiangnan University Medical Center, Wuxi, China. n.feng@njmu.edu.cn.

Funding

Fundamental Research Funds for Central Universities of the Central South University 2242023K5007National Natural Science Foundation of China 81972402National Natural Science Foundation of China 8207103732National Natural Science Foundation of China 82173169
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39528875
PMCPMC11555054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.